Hematology TimesCAR is feasible in majority of ALL patients, team saysJanuary 2, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALL
Hematology TimesCAR produces durable responses in B-cell ALLJanuary 2, 2015Leukemia, Myelodysplasia, TransplantationALL
Hematology NewsCAR-T cell therapy rolls on in pediatric ALLDecember 17, 2014PediatricsTransfusion MedicineALLCellular Therapy
Hematology TimesBlinatumomab confirmed as treatment option in MRD+ ALLDecember 17, 2014Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesResearchers show CTL019 cells proliferate and persistDecember 16, 2014Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology NewsNilotinib plus chemotherapy pays off for older patients with Ph+ALLDecember 9, 2014ALL
Oncology PracticeYoung adults with ALL have better survival with pediatric regimensDecember 8, 2014Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesFDA approves first anti-CD19 drugDecember 4, 2014Leukemia, Myelodysplasia, TransplantationPharmacyALL
Hematology TimesLeukemia survival rates vary widely across the globeNovember 26, 2014Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesCAR T-cell therapy gets breakthrough designationNovember 26, 2014Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
Hematology TimesFDA grants CAR T-cell therapy orphan designationNovember 19, 2014Leukemia, Myelodysplasia, TransplantationPharmacyALL
Hematology TimesRNAi therapy may eliminate resistance in B-ALLNovember 6, 2014Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesRisk-directed therapy improves survival in ALLOctober 8, 2014Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesProduct appears safe, effective in rel/ref ALLOctober 2, 2014Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesTargeting drug resistance earlierOctober 1, 2014Leukemia, Myelodysplasia, TransplantationALL
